December 4, 2021

Volume XI, Number 338

Advertisement
Advertisement

December 03, 2021

Subscribe to Latest Legal News and Analysis

December 02, 2021

Subscribe to Latest Legal News and Analysis

December 01, 2021

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
24
Oct
SEC Asks Public Companies to Disclose Cyber Attacks Barnes & Thornburg LLP
24
Oct
U.S. Patent Reform in 2011: President Signs the America Invents Act Much Shelist, P.C.
22
Oct
America Invents Act: U.S. Will Become a First-to-File Patent System Michael Best & Friedrich LLP
21
Oct
Tenth Circuit Finds Potential Insurance Coverage for Patent Infringement Claims Under “Advertising Injury” Provisions Morgan, Lewis & Bockius LLP
20
Oct
On Remand from the Federal Circuit, the District Court in Lucent v. Microsoft Rules Lucent Again Failed to Properly Apply the Entire Market Value Rule Morgan, Lewis & Bockius LLP
19
Oct
Federal Circuit Reverses District Court Decision and Rules that Isolated DNA Sequences Are Patent-Eligible Subject Matter Morgan, Lewis & Bockius LLP
18
Oct
Federal Circuit Affirms ITC's Determination that Litigation Generally Cannot Be Used to Establish a Domestic Industry McDermott Will & Emery
18
Oct
Infringement by Unobvious Changes – A Look (Way) Back Schwegman, Lundberg & Woessner, P.A.
18
Oct
The Coverage Question Risk and Insurance Management Society, Inc. (RIMS)
17
Oct
Obviousness = Equivalence? Saint-Gobain v. Siemens Schwegman, Lundberg & Woessner, P.A.
15
Oct
Be Aware of Trademark and Patent Scams Sterne, Kessler, Goldstein & Fox P.L.L.C.
14
Oct
Easy Steps To Avoid Having Your Brand Used In An Adult Website Address von Briesen & Roper, s.c.
14
Oct
USPTO Implements New Policy Change on Reissues in View of Recent Federal Circuit Decision McDermott Will & Emery
13
Oct
Federal Circuit Wraps Up 10-Year Patent Infringement Suit for Tobacco Curing Patents McDermott Will & Emery
12
Oct
Underlying Invention and Not Category Literally Invoked by Claim Determines Subject Matter Eligibility McDermott Will & Emery
11
Oct
Federal Circuit Affirms Non-Obviousness Summary Judgment for Novel Formulation of Prior Art Active Drug Compound McDermott Will & Emery
11
Oct
Defendant Not Allowed to Appeal Denial of a 12(b)(6) Motion to Dismiss After Trial McDermott Will & Emery
10
Oct
SCO Can’t Claim Ownership of the UNIX Operating System McDermott Will & Emery
9
Oct
The Top Five Intellectual Property Traps in M&A Transactions McDermott Will & Emery
7
Oct
UK Supreme Court Holds that U.S. Copyright Claims Are Justiciable in English Courts McDermott Will & Emery

Pages

Advertisement
Advertisement